Visitors Now:
Total Visits:
Total Stories:
Profile image
Story Views

Last Hour:
Last 24 Hours:

Worldwide Asthma Therapeutics Market 2016 Trend, Analysis and Overview

Monday, October 10, 2016 3:23
% of readers think this story is Fact. Add your two cents.

(Before It's News)

Increasing allergic rhinitis is a major factor for allergic asthma leading to increase in research for the development of allergic immunotherapies for the treatment of asthma. The global asthma therapeutics market will observe a moderate growth during the forecast period because of loss of patent exclusivity of the major drugs, allowing the entry of generics into the market. This will lead to the erosion of the market share of the major asthma drugs. However, the presence of late-stage pipeline molecules will drive the market. An increase in the prevalence of asthma and the use of combination drugs will drive the growth of the market during the forecast period.

Publisher’s analysts forecast the global asthma therapeutics market to grow at a CAGR of 4.31% during the period 2016-2020.

For more information about this report:      

Covered in this report 
The report covers the present scenario and the growth prospects of the global asthma therapeutics market for 2016-2020. To calculate the market size, Publisher considers the revenue generated from the sales of brand-name, generic, and off-label drugs used for the prevention and treatment of asthma. The report also considers the revenues to be generated from the sales of drugs that are expected to be launched into the market along with the decline in revenues from patent expiries of marketed drugs during the forecast period.

The market is divided into the following segments based on geography: 
- Americas

Publisher’s report, Global Asthma Therapeutics Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market. 

Key vendors 
- AstraZeneca
- Boehringer Ingelheim
- F. Hoffmann-La Roche
- Merck 


Request Sample Copy at  


Other prominent vendors 
- ALK-Abello
- Amgen
- Array BioPharma
- Asmacure
- Astellas Pharma
- Atopix Therapeutics
- Axikin Pharmaceuticals
- Chiesi Farmaceutici
- Dynavax Technologies Corp.
- Horizon Pharma
- Hovione Scientia
- Invion
- Ivax
- Kissei Pharmaceutical
- Kyowa Hakko Kirin
- MediciNova
- Mitsubishi Tanabe Pharma Corporation
- Mundipharma
- Nycomed
- Oxagen Limited
- Palobiofarma
- Pearl Therapeutics
- Pharmaking
- Pharmaxis
- Pulmagen Therapeutics
- Regeneron Pharmaceuticals
- Revalesio 
- RSPR Pharma AB
- SAMA Pharmaceuticals
- Sanofi
- Skyepharma
- SolAeroMed
- Stallergenes
- Sterna Biologicals
- Synairgen
- Theron Pharmaceuticals
- UCB Pharma
- Vectura
- Verona Pharma
- Whanin Pharmaceutical Company 

Market driver 
- Huge market potential for mAbs
- For a full, detailed list, view our report 

Market challenge 
- Increased preference for CAM
- For a full, detailed list, view our report 

Market trend 
- Innovative technologies for drug delivery
- For a full, detailed list, view our report 


Inquire for Report at        


Contact Us:

Call: +1-646-491-9876

Report abuse


Your Comments
Question   Razz  Sad   Evil  Exclaim  Smile  Redface  Biggrin  Surprised  Eek   Confused   Cool  LOL   Mad   Twisted  Rolleyes   Wink  Idea  Arrow  Neutral  Cry   Mr. Green

Top Stories
Recent Stories



Email this story
Email this story

If you really want to ban this commenter, please write down the reason:

If you really want to disable all recommended stories, click on OK button. After that, you will be redirect to your options page.